Search clinical trials for: Ixabepilone, 32 mg/m^2 Lapatinib, 1000 mg
Total 146 results
-
R-PharmGlaxoSmithKlineTerminatedLocally Advanced or Metastatic Breast CancerUnited States, Italy, Australia
-
R-PharmTerminated
-
R-PharmCompletedNon-small Cell Lung Cancer (NSCLC)Japan
-
CicloMed LLCCmed Clinical ServicesCompletedAdvanced Solid TumorsUnited States
-
GlaxoSmithKlineCompletedDiabetes Mellitus, Type 2United States, Taiwan, Argentina, Canada, Philippines, Korea, Republic of, Mexico, Brazil, Pakistan
-
GlaxoSmithKlineCompletedNeoplasms, BreastUnited Kingdom, United States, Peru, Israel, Poland, Russian Federation, Korea, Republic of, Thailand, Pakistan, Hungary, India, Canada, France, Mexico, Malaysia, Singapore
-
Eisai Inc.CompletedSoft Tissue SarcomaUnited States, France, United Kingdom, Germany, Spain, Belgium, Argentina, Israel, Poland, Romania, Korea, Republic of, Canada, Netherlands, Australia, New Zealand, Singapore, Brazil, Russian Federation, Austria, Thailand, Italy, ... and more
-
EMD Serono Research & Development Institute, Inc.Merck KGaA, Darmstadt, GermanyCompletedAdvanced Solid TumorUnited States
-
R-PharmCompletedAdvanced/Metastatic Non-Small Cell Lung CancerGermany, Korea, Republic of, Russian Federation, Taiwan, Australia, Italy, France, United States, Argentina, Spain
-
R-PharmCompletedMetastatic Breast CancerItaly, United Kingdom, United States, France, Spain
-
HighField Biopharmaceuticals CorporationRecruiting
-
SunovionCompletedPediatric Attention Deficit Hyperactivity DisorderUnited States
-
Millennium Pharmaceuticals, Inc.CompletedMyelodysplastic Syndromes | Leukemia, Myeloid, AcuteJapan, Taiwan, Korea, Republic of
-
Handok Inc.Completed
-
AIO-Studien-gGmbHTaiho Pharmaceutical Co., Ltd.; Nordic Pharma SASCompletedEsophageal Neoplasms | Gastric Adenocarcinoma | Esophageal Adenocarcinoma | Gastroesophageal Junction Adenocarcinoma | Gastric Neoplasm | Unresectable, Locally Advanced or Metastatic, Adenocarcinoma of the Stomach, or of the Gastro Esophageal JunctionGermany
-
Hoffmann-La RocheCompletedColorectal CancerFrance, Israel, Italy, Spain, Sweden, Hong Kong, Australia, Canada, Switzerland, United States, Ireland, Denmark, Germany, Taiwan, Russian Federation, China, New Zealand, Austria, United Kingdom, Hungary, Thailand, South Africa, Mexico and more
-
Medical College of WisconsinCompletedRelapsed Adult AMLUnited States
-
Dong-A ST Co., Ltd.Completed
-
Merck Sharp & Dohme LLCTerminated
-
Centre Hospitalier Universitaire, AmiensMerck Serono International SACompletedRenal Disorder Associated With Type II Diabetes MellitusFrance
-
Dong-A ST Co., Ltd.CompletedType 2 Diabetes MellitusKorea, Republic of
-
Al B. Benson, III, MDCelgene Corporation; Big Ten Cancer Research ConsortiumCompletedGastric Cancer | Gastro-Esophageal Junction AdenocarcinomaUnited States
-
Prestige Biopharma LimitedRecruitingPancreatic CancerSpain, United States
-
Daiichi Sankyo, Inc.CompletedLiver Neoplasms | Advanced Hepatocellular Carcinoma | Liver Cancer | Hepatic CancerKorea, Republic of, Taiwan, United States, Japan
-
AstraZenecaParexelCompletedType 2 Diabetes MellitusUnited States
-
Janssen Research & Development, LLCCompleted
-
GlaxoSmithKlineCompletedNeoplasms, BreastUnited States, Korea, Republic of
-
Merck Sharp & Dohme LLCCompletedSmall Cell Lung Cancer | Solid Tumor | Non-small Cell Lung Cancer
-
Global Alliance for TB Drug DevelopmentCompletedTuberculosis | Tuberculosis, PulmonaryUnited States
-
Institut du Cancer de Montpellier - Val d'AurelleCompletedMetastatic Pancreatic AdenocarcinomaFrance
-
Millennium Pharmaceuticals, Inc.Johnson & Johnson Pharmaceutical Research & Development, L.L.C.CompletedMantle Cell LymphomaChina, Belgium, Thailand, United States, Spain, Canada, Colombia, Italy, Morocco, Brazil, Turkey, Chile, Malaysia, Israel, Portugal, Singapore, Russian Federation, Philippines, Tunisia, Austria, Czechia, Germany, Hungary, India, Poland, R... and more
-
Janssen Research & Development, LLCTerminatedMultiple MyelomaCanada, United States, Belgium, Poland, Italy, France, Spain, Brazil, Russian Federation, Denmark, Greece, Germany, Netherlands
-
CelgeneCompletedPhase 2 Clinical Trial of NPI-0052 in Patients With Relapsed or Relapsed/Refractory Multiple MyelomaMultiple MyelomaUnited States
-
Merck KGaA, Darmstadt, GermanyCompletedNon-Small Cell Lung Cancer (NSCLC)Germany
-
Medical College of WisconsinBarbara Ann Karmanos Cancer Institute; Cornerstone PharmaceuticalsRecruitingPancreas AdenocarcinomaUnited States
-
Merck Sharp & Dohme LLCCompletedNon-small Cell Lung CancerUnited States, Australia, France, Germany, Korea, Republic of, New Zealand, Poland, Russian Federation, Spain, United Kingdom
-
Bial - Portela C S.A.Completed
-
GlaxoSmithKlineTerminated
-
AstraZenecaCompleted
-
Corcept TherapeuticsGynecologic Oncology GroupActive, not recruitingFallopian Tube Neoplasms | Peritoneal Neoplasms | Ovarian NeoplasmUnited States, Argentina, Australia, Belgium, Brazil, Canada, France, Hungary, Israel, Italy, Korea, Republic of, Poland, Spain, United Kingdom
-
Janssen Research & Development, LLCCompleted
-
Sun Yat-sen UniversityGuangzhou No.12 People's Hospital; Kaiping Central HospitalUnknown
-
The University of Texas Health Science Center,...Completed
-
Academisch Medisch Centrum - Universiteit van Amsterdam...RecruitingNAFLD | Liver Fibrosis | NASH With FibrosisNetherlands
-
University of Texas Southwestern Medical CenterGenentech, Inc.; CelgeneCompletedLung Cancer | Metastatic CancerUnited States
-
Pierre Fabre MedicamentCompleted
-
Centre Hospitalier Universitaire de Saint EtienneRecruitingArthropathy of HipFrance
-
NYU Langone HealthActive, not recruiting
-
AstraZenecaCompleted
-
Medical College of WisconsinRecruitingGlioblastomaUnited States